How Belite Bio, a small, under-the-radar drugmaker, emerged as one of biotech's best performing IPOs
BioPharma
Source: biopharmadive.com
Lin Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lin Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lin Bioscience Today - Breaking & Trending Today
Belite Bio stock soars 65% in wake of strong IPO performance
Belite Bio (BLTE) stock soared 65% on Tuesday on the heels of a strong performance last Friday following its $36M initial public offering
Source: seekingalpha.com
HilleVax's IPO hauls in $200M for clinical test of VLP norovirus vaccine from Takeda
Takeda Pharmaceutical spinout HilleVax broke the biotech IPO drought with a $200 million stock market debut for clinical development of a norovirus vaccine. Two eye health companies marked the other IPO activity: Belite Bio went public while Bausch + Lomb set financial terms for what could become one of the biggest IPOs of the year.
Source: medcitynews.com
Eye drug developer Belite Bio stock soars 160% following $36M IPO
Eye drug developer Belite Bio (BLTE) stock soared 160% following its $36M initial public offering. Shares of BLTE opened at $12.50 after pricing at $6 per American Depositary Share
Source: seekingalpha.com
Belite Bio Begins IPO Effort To Advance Eye Disease Treatments (Pending:BLTE)
Belite Bio has filed to raise an undisclosed amount in an IPO. The firm is developing treatment candidates for eye diseases. Read more about BLTE's IPO here.
Source: seekingalpha.com